Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 3,586 | 4,111 | 11,202 | 9,265 | 46,793 |
| Cost of Goods | N/A | 2,334 | 10,775 | 9,119 | 12,077 |
| Gross Profit | 3,586 | 1,777 | 427 | 146 | 34,716 |
| Operating Expenses | 126,016 | 83,553 | 59,279 | 43,664 | 41,248 |
| Operating Income | -122,430 | -81,442 | -58,077 | -43,399 | -6,455 |
| Interest Expense | 0 | 927 | 1,576 | 1,796 | 1,337 |
| Other Income | 4,350 | 819 | 530 | 396 | 5,259 |
| Pre-tax Income | -118,080 | -81,550 | -59,123 | -44,799 | -2,533 |
| Net Income Continuous | -118,080 | -81,550 | -59,123 | -44,799 | -2,533 |
| Net Income | $-118,080 | $-81,550 | $-59,123 | $-44,799 | $-2,533 |
| EPS Basic Total Ops | -19.79 | -15.29 | -15.29 | -16.94 | -1.20 |
| EPS Basic Continuous Ops | -19.80 | -15.33 | -15.36 | -17.00 | -1.19 |
| EPS Diluted Total Ops | -19.79 | -15.29 | -15.29 | -16.94 | -1.20 |
| EPS Diluted Continuous Ops | -19.80 | -15.33 | -15.36 | -17.00 | -1.19 |
| EBITDA(a) | $-118,934 | $-79,863 | $-55,600 | $-39,221 | $-608 |